287 related articles for article (PubMed ID: 37223034)
1. Animal models of the placenta accreta spectrum: current status and further perspectives.
Ma Y; Hu Y; Ma J
Front Endocrinol (Lausanne); 2023; 14():1118168. PubMed ID: 37223034
[TBL] [Abstract][Full Text] [Related]
2. New insights into the etiopathology of placenta accreta spectrum.
Jauniaux E; Jurkovic D; Hussein AM; Burton GJ
Am J Obstet Gynecol; 2022 Sep; 227(3):384-391. PubMed ID: 35248577
[TBL] [Abstract][Full Text] [Related]
3. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging.
Jauniaux E; Collins S; Burton GJ
Am J Obstet Gynecol; 2018 Jan; 218(1):75-87. PubMed ID: 28599899
[TBL] [Abstract][Full Text] [Related]
4. Uterine damage induces placenta accreta and immune imbalance at the maternal-fetal interface in the mouse.
Zhou J; Chen H; Xu X; Liu Y; Chen S; Yang S; He F; Yu B
Placenta; 2022 Mar; 119():8-16. PubMed ID: 35066308
[TBL] [Abstract][Full Text] [Related]
5. Can immunohistochemistry improve the pathological diagnosis of placenta accreta spectrum (PAS) disorders?
Losi L; Botticelli L; Mancini L; Negro R; Hanspeter E; Dematté E; Grandi G; Facchinetti F; Veneziano M; Malagoli C; Masini M; Fabbiani L; Rivasi F
Arch Gynecol Obstet; 2024 Jun; 309(6):2605-2612. PubMed ID: 37535133
[TBL] [Abstract][Full Text] [Related]
6. A mouse model of placenta accreta spectrum.
Burke SD; Zsengellér ZK; Karumanchi SA; Shainker SA
Placenta; 2020 Sep; 99():8-15. PubMed ID: 32716845
[TBL] [Abstract][Full Text] [Related]
7. Failure of placental detachment in accreta placentation is associated with excessive fibrinoid deposition at the utero-placental interface.
Jauniaux E; Hussein AM; Elbarmelgy RM; Elbarmelgy RA; Burton GJ
Am J Obstet Gynecol; 2022 Feb; 226(2):243.e1-243.e10. PubMed ID: 34461077
[TBL] [Abstract][Full Text] [Related]
8. Identification of altered miRNAs and their targets in placenta accreta.
Murrieta-Coxca JM; Barth E; Fuentes-Zacarias P; Gutiérrez-Samudio RN; Groten T; Gellhaus A; Köninger A; Marz M; Markert UR; Morales-Prieto DM
Front Endocrinol (Lausanne); 2023; 14():1021640. PubMed ID: 36936174
[TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of impact of post-Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder.
Hussein AM; Elbarmelgy RA; Elbarmelgy RM; Thabet MM; Jauniaux E
Ultrasound Obstet Gynecol; 2022 Apr; 59(4):474-482. PubMed ID: 34225385
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Extravillous Intermediate Trophoblast Invasion Depth and Distribution Pattern Between Placenta Accreta and Non-Accreta.
Suardi D; Toriq H; Tuasikal RR; Mose JC; Susiarno H; Sukarsa MRA; Yantisetiasti A; Mantilidewi KI; Kireina J; Hernowo BS; Hidayat YM
Med Sci Monit; 2023 Apr; 29():e939125. PubMed ID: 37060171
[TBL] [Abstract][Full Text] [Related]
11. Extravillous trophoblast invasion in placenta accreta is associated with differential local expression of angiogenic and growth factors: a cross-sectional study.
Duzyj CM; Buhimschi IA; Laky CA; Cozzini G; Zhao G; Wehrum M; Buhimschi CS
BJOG; 2018 Oct; 125(11):1441-1448. PubMed ID: 29469945
[TBL] [Abstract][Full Text] [Related]
12. Interobserver agreement in MRI assessment of severity of placenta accreta spectrum disorders.
Finazzo F; D'antonio F; Masselli G; Forlani F; Palacios-Jaraquemada J; Minneci G; Gambarini S; Timor-Tritsch I; Prefumo F; Buca D; Liberati M; Khalil A; Cali G
Ultrasound Obstet Gynecol; 2020 Apr; 55(4):467-473. PubMed ID: 31237043
[TBL] [Abstract][Full Text] [Related]
13. Immune cell infiltrate at the utero-placental interface is altered in placenta accreta spectrum disorders.
Hecht JL; Karumanchi SA; Shainker SA
Arch Gynecol Obstet; 2020 Feb; 301(2):499-507. PubMed ID: 32025844
[TBL] [Abstract][Full Text] [Related]
14. Placenta accreta spectrum: value of placental bulge as a sign of myometrial invasion on MR imaging.
Jha P; Rabban J; Chen LM; Goldstein RB; Weinstein S; Morgan TA; Shum D; Hills N; Ohliger MA; Poder L
Abdom Radiol (NY); 2019 Jul; 44(7):2572-2581. PubMed ID: 30968183
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound-histopathologic features of the utero-placental interface in placenta accreta spectrum.
Jauniaux E; Zosmer N; Subramanian D; Shaikh H; Burton GJ
Placenta; 2020 Aug; 97():58-64. PubMed ID: 32792064
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of classic and novel ultrasound signs of placenta accreta spectrum.
Skupski DW; Duzyj CM; Scholl J; Perez-Delboy A; Ruhstaller K; Plante LA; Hart LA; Palomares KTS; Ajemian B; Rosen T; Kinzler WL; Ananth C;
Ultrasound Obstet Gynecol; 2022 Apr; 59(4):465-473. PubMed ID: 34725869
[TBL] [Abstract][Full Text] [Related]
17. Effects of local decidua on trophoblast invasion and spiral artery remodeling in focal placenta creta - an immunohistochemical study.
Hannon T; Innes BA; Lash GE; Bulmer JN; Robson SC
Placenta; 2012 Dec; 33(12):998-1004. PubMed ID: 23040667
[TBL] [Abstract][Full Text] [Related]
18. Prenatal ultrasound staging system for placenta accreta spectrum disorders.
Cali G; Forlani F; Lees C; Timor-Tritsch I; Palacios-Jaraquemada J; Dall'Asta A; Bhide A; Flacco ME; Manzoli L; Labate F; Perino A; Scambia G; D'Antonio F
Ultrasound Obstet Gynecol; 2019 Jun; 53(6):752-760. PubMed ID: 30834661
[TBL] [Abstract][Full Text] [Related]
19. Unraveling the molecular mechanisms driving enhanced invasion capability of extravillous trophoblast cells: a comprehensive review.
Lin Z; Wu S; Jiang Y; Chen Z; Huang X; Wen Z; Yuan Y
J Assist Reprod Genet; 2024 Mar; 41(3):591-608. PubMed ID: 38315418
[TBL] [Abstract][Full Text] [Related]
20. Placenta accreta: pathogenesis of a 20th century iatrogenic uterine disease.
Jauniaux E; Jurkovic D
Placenta; 2012 Apr; 33(4):244-51. PubMed ID: 22284667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
